Noida, UP -- (SBWIRE) -- 06/26/2014 -- Genome based sequencing provide opportunity to understand the importance of genetic variants of patients and imparts personalized treatment. The Personalized Cancer Whole Genome Sequencing Market has evolved due to advancement in the technology witnessing immense growth in the field of genomics. The upfront cost of sequencing is decreasing at an unprecedented rate making whole genome sequencing feasible in research and clinical care. Based on above mentioned facts, US Personalized Whole Genome Sequencing stood at US$ 65 Million and will grow at a CAGR of around 29% by end of 2018.

Research Analysis and Highlights

The report, “US Personalized Cancer Genome Sequencing Market Outlook 2018”, by RNCOS which is spread around 65 pages provides an in-depth research and rational analysis of the current status and expected Whole Genome Sequencing Market. Besides, it facilitates the current and potential of the Whole Genome Sequencing Market. The report prudently analyzed various factors such as cancer prevalence, incidence rates, and affordable states for WGS across United States. The report also covers the strengths and weaknesses of market players. A detailed study of regulatory insights has been covered in the report. Further, the report also illustrates the market restraints that impact the potential of Whole Genome Sequencing market.

Some of the key findings of the report are:

- Highly Untapped Market: A Profitable Option
- Rising Incidence Rate in US States viz a viz household income provide growth opportunity for market players

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM672.htm

Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm

ABOUT RNCOS
RNCOS is a leading industry research and consultancy firm incorporated in 2002. As a pioneer in syndicate market research, our vision is to be a global leader in the industry research space by providing research reports and actionable insights to companies across a range of industries such as Healthcare, IT and Telecom and Retail etc. We offer comprehensive industry research studies, bespoke research and consultancy services to Fortune 1000, Trade associations, and Government agencies worldwide.